Portea Medical & ConvaTec join hands to bring Ostomy and Wound Management Home

Bangalore Portea Medical, India’s largest out-of-hospital consumer healthcare services company, has recently partnered with ConvaTec. ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. As part of this tie-up, Portea in partnership with ConvaTec will offer ostomy care and wound management services in all major Indian cities.

The tie-up will enable patients to get discharged from hospitals post-surgery to avail products and services at the comfort of their homes. They will also have access to other services like nutrition consultation and physiotherapy along with visits by trained and experienced nurses from Portea.

Speaking about this, Meena Ganesh, MD and CEO, Portea Medical, said, “Post-surgery management and proper ostomy services are critical to recovery in patients. We are happy to tie up with ConvaTec to offer these services to our customers who need them. The idea is to help them recuperate in their homes comfortably with all the relevant services and products at their disposal.,. With ConvaTec’s latest technology, the entire gamut of care will be available to them ensuring that they have a better quality of life. We have recently introduced various at-home services including dialysis and chemotherapy as well, all of which are aimed at making lives better for our customers.”

Adding further, Rahul Garg, Country General Manager, ConvaTec, said, “Being a global medical solutions company focused on chronic conditions, we aim to bring best-in-class care to our patients at an affordable cost. Our partnership with Portea Medical comes at a time when the global pandemic has led to an increase in the demand for at-home care for various medical conditions.

Portea Medical has been delivering consistent, high-quality care in various parts of the country. The company has catered to over 1 million patients in their home environment offering an extensive range of services for chronic diseases, elderly care, post-surgery care, diabetes management, chemotherapy at home, and other diseases or injuries requiring long-term care. Through this partnership, patients will be able to access world class care with improved outcomes and reduced cost of care.

Related Posts

Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

MOU signed for Patient Referrals, Tele-Consultations and Specialist Healthcare Collaboration Delhi NCR: Unveiled not long ago, Yashoda Medcity’s reputation as being best in class healthcare facility in Delhi NCR has…

Liver enters FATal Straits in India, AIIMS Experts red flag

In first for India, World Congress of Gastroenterology comes calling to asses GI disease burden New Delhi: As global and national burden of digestive diseases reach a critical crossroads, World…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre